Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug

By Breistol K.   Hendriks H.R.   Fodstad .  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1143-1149

Elsevier

Access to resources Recommend Favorite

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts

By Hill B.T.   Fiebig H.-H.   Waud W.R.   Poupon M.-F.   Colpaert F.   Kruczynski A.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 512-520

Elsevier

Access to resources Recommend Favorite

Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts

By Langdon S.P.   Ritchie A.A.   Muir M.   Dodds M.   Howie A.F.   Leonard R.C.F.   Stockman P.K.   Miller W.R.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 384-388

Elsevier

Access to resources Recommend Favorite

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice

By Sirova Milada   Strohalm Jiri   Subr Vladimir   Plocova Daniela   Rossmann Pavel   Mrkvan Tomas   Ulbrich Karel   Rihova Blanka  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 35-47

Springer Publishing Company

Access to resources Recommend Favorite

The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O 6 -alkylguanine-DNA-alkyltransferase of human tumour xenografts

By D'Incalci M.   Bonfanti M.   Pifferi A.   Mascellani E.   Tagliabue G.   Berger D.   Fiebig H.H.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1749-1755

Elsevier

Access to resources Recommend Favorite